Chris Tam

Company: Integrated Nanotherapeutics
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Practical Approaches for Creating a Compelling Preclinical Data Package for IND Submission to Move ASIT Therapies from the Lab to the Clinic 1:00 pm
• Highlighting the importance of robust clinical data to secure funding, partnerships, and regulatory buy-in in a new area with limited proof-of-concept studies • Turbocharging the development of humanized mouse models and organoids to accurately replicate human autoimmune diseases for increased preclinical data • Evaluating strategies for first in-human trials: when and where should the…Read more
day: Custom Day Two